Lindbrook Capital, LLC Recursion Pharmaceuticals, Inc. Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 956 shares of RXRX stock, worth $10,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
956
Previous 710
34.65%
Holding current value
$10,066
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RXRX
# of Institutions
331Shares Held
276MCall Options Held
2.53MPut Options Held
2.68M-
Vanguard Group Inc Valley Forge, PA34MShares$358 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$341 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$262 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$182 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$154 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.9B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...